Ischemic heart disease decisions — 2025

The Board dismissed the appeals for service connection for ischemic heart disease, syncope, diabetes mellitus, Type-II, diabetic peripheral neuropathy, bilateral hearing loss, and fracture of two upper teeth due to procedural defects in the Veteran's filings.

The Board remands the claims for service connection for lymphoproliferative disorder, CAD, and DM due to a need for a VA medical opinion.

The Board remands the claims for service connection for ischemic heart disease, diabetes mellitus type II, and peripheral neuropathy of various extremities to obtain additional evidence and ensure adequate medical opinions.

The Board granted an earlier effective date of August 8, 2012, for the award of service connection for coronary artery disease, congestive heart failure with angina, and atrial fibrillation, status post myocardial infarction.

The Board denied service connection for aortic valve disease, ischemic heart disease (IHD), and hypertension as the evidence did not support a finding that these conditions began during or are related to active service. The claims for squamous cell carcinoma, chloracne, and chronic inflammatory demyelinating polyneuropathy were remanded for further development.

The Board granted eligibility to attorney fees based on the past-due benefits awarded in the January 2024 rating decision.

The Board denied the veteran's appeal for an earlier effective date for service connection for hypertension and arteriosclerotic heart disease with valvular heart disease, atrioventricular block, and heart palpitations.

The claims for service connection for peripheral neuropathy in the left and right upper extremities were dismissed as moot, while the claim for an earlier effective date for coronary artery disease was remanded.

The Board denied the appellant's eligibility for direct payment of attorney fees from benefits resulting from the March 2024 grant of past-due benefits.

The Board remands the claims for further development and to correct duty to assist errors.

The appeal for service connection for a heart disorder and a respiratory disorder was dismissed due to the Veteran's death during the pendency of the appeal.

The Board remands the claims for service connection for hypertension, coronary artery disease (CAD), atherosclerosis, kidney disease, and peripheral vascular disease of the bilateral lower extremities to obtain additional medical opinions.

The Board remands the claims for service connection for heart disease, hypertension, diabetes mellitus II, and a skin/skin rash disorder due to the RO's failure to comply with the Board's previous directive.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, as the November 2023 TERA opinions are inadequate.

The appeal for service connection for diabetes mellitus, ischemic heart disease, a kidney condition, sinus bradycardia, a skin rash, a bladder disability, and an enlarged prostate was dismissed due to the Veteran's untimely filing of a VA Form 10182.

The Board granted an effective date of May 14, 2021, for the award of service connection for coronary artery disease with arteriosclerotic heart disease and a 20 percent rating for colonic adenocarcinoma residuals. The claims for earlier effective dates and higher ratings were remanded.

The Board granted service connection for polycythemia vera, to include as due to contaminated water at Camp Lejeune, and granted a TDIU prior to September 11, 2024. The initial disability ratings in excess of 60 percent for the heart condition and a compensable rating for the chest scar were denied.

The Board denied service connection for multiple conditions, including a thyroid condition, bilateral foot disability, tinnitus, cervical spine disability, hypertension heart condition, lumbar spine disability, and psychiatric disability, as the evidence did not support a finding that any of these conditions were incurred in or related to active service.

The Board granted a total disability rating based on individual unemployability due to service-connected disabilities from April 14, 2020, to July 9, 2023.

The Board granted service connection for coronary artery disease based on a presumption of herbicide exposure during the veteran's active duty.